Table 1.
Laboratory values | Admission | Hospitalization | 6-Month follow-up | Reference ranges |
---|---|---|---|---|
Standard blood samples | ||||
Potassium, mmol/L | 3.5 | 3.8 | 3.5–4.6 | |
Sodium, mmol/L | 140 | 139 | 137–145 | |
Calcium, mmol/L | 2.20 | 2.52 | 2.20–2.55 | |
Albumin, g/L | 36 | 36 | 36–48 | |
CRP, mg/L | 6.9 | 5.8 | <8.0 | |
Leucocytes, ×109/L | 6.2 | 9.1 | 3.50–10.0 | |
Creatinine, µmol/L | 61 | 62 | 60–105 | |
Hematology | ||||
Hemoglobin, mmol/L | 9.3 | 8.7 | 10.5 | 8.3–10.5 |
Erythrocytes MCV, fl | 101 | 99 | 93 | 82–102 |
Erythrocytes MCHC, mmol/L | 22.1 | 21.5 | 21.1 | 19.7–22.2 |
Platelets, ×109/L | 384 | 346 | 342 | 145–350 |
Iron, µmol/L | 26 | 9–34 | ||
Vitamin B12, pmol/L | 234 | 352 | 200–600 | |
Methylmalonic acid, µmol/L | >10 | 0.08–0.28 | ||
Folate, µmol/L | 21 | >9 | ||
Homocysteine, µmol/L | 92 | 9.5 | <10 | |
Thrombosis and hemostasis | ||||
INR | 1.2 | 1.2 | 1.1 | <1.2 |
APTT | 23 | 26 | 20–29 | |
Fibrin D-dimer, mg/L | 3.0 | 0.25 | ||
Cardiac troponin I, ng/L | <3 | <47 | ||
Cardiolipinantibodies, IgG, ×103 IU/L | 16 | <20 | ||
Cardiolipinantibodies, IgM, ×103 IU/L | <10 | <20 | ||
Lupus anticoagulant | 1.2 | <1.4 | ||
Coagulation factor VIII, ×103 IU/L | 1.34 | 0.66–1.55 | ||
Antithrombin, ×103 IU/L | 0.84 | 0.80–1.20 | ||
Protein-C, ×103 IU/L | 0.93 | 0.74–1.50 | ||
Protein-S, ×103 IU/L | 0.70 | 0.69–1.37 | ||
DNA-F2-gene | Normal | |||
DNA-F5-gene | Normal | |||
Anti-beta-2-glycoprotein 1 antibodies, IgG, ×103 IU/L | <10 | <20 | ||
Anti-beta-2-glycoprotein 1 antibodies, IgM, ×103 IU/L | <10 | <20 | ||
Lumbar puncture | ||||
Leucocytes, ×106/L | 0 | <5 | ||
Mononuclear leucocytes, ×106/L | 0 | <4 | ||
Polynuclear leucocytes, ×106/L | 0 | <0 | ||
Glucose, mmol/L | 3.6 | 2.5–4.5 | ||
Protein, g/L | 0.26 | 0.15–0.50 | ||
Erythrocytes, ×106/L | 0 | 0 |
CRP – C-reactive protein; MCV – mean cell volume; MCHC – mean cell hemoglobin concentration; INR – international normalized ratio; APTT – activated partial thromboplastin time; IU – international units.